New data indicates that a blood clotting syndrome is more common among people who recently received a J&J vaccine.
A committee of US medical experts that advises the government voted Tuesday in favor of recommending Pfizer and Moderna’s anticovid vaccines over Johnson & Johnson’s, given their lower protection and higher risks.
The vote was unanimous (15-0) supporting the recommendation. “I would not recommend a Janssen vaccine to members of my family,” Beth Bell, a clinical professor at the University of Washington, said of her vote, referring to the Johnson & Johnson vaccine.
The CDC has recorded 54 U.S. cases of thrombosis with thrombocytopenia syndrome or TTS since the vaccine became available. Nine people died: seven women and two men.
ACIP members considered the new data and compared it with numerous studies showing that the J&J vaccine is less effective than the Moderna and Pfizer / BioNTech vaccines in preventing infections.
Modern Booster or Pfizer Vaccine Works Best for Johnson & Johnson Vaccinates, Preliminary Study Finds
New data indicates that a rare blood clotting syndrome is more common among people who recently received a J&J vaccine than previously believed. (I)
Paul is a talented author and journalist with a passion for entertainment and general news. He currently works as a writer at the 247 News Agency, where he has established herself as a respected voice in the industry.
